Report: PharmaPoint Hepatitis C Virus - United States Drug Forecast and Market Analysis Report Insights
• Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation • The disease is often asymptomatic, but infected patients may experience fatigue, joint pain, itchy skin or jaundice • Since there is no effective vaccine against HCV, the market is driven by therapeutics • Currently, drug combinations containing pegylated interferon and ribavirin are used to treat HCV infection • Entrance of next-generation HCV therapies is expected to fundamentally change the HCV treatment algorithm www.researchonglobalmarkets.com